TransMedics (TMDX) Invested Capital (2025 - 2026)

TransMedics (TMDX) posted quarterly Invested Capital of $15.0 million for Q1 2026, up 50.0% quarter-over-quarter from $10.0 million in Q4 2025.

TransMedics (TMDX) Invested Capital (2025 - 2026) Analysis & Trends

TransMedics' Invested Capital history runs 2 years deep, the most recent figure standing at $15.0 million for Q1 2026.

In Q1 2026, Invested Capital changed N/A year-over-year to $15.0 million; the TTM figure through Mar 2026 stood at $30.0 million (changed N/A YoY), while the FY2025 annual figure was $10.0 million, changed N/A from the prior year.
Invested Capital for Q1 2026 stood at $15.0 million, up from $10.0 million in the prior quarter.
The five-year high for Invested Capital was $15.0 million in Q1 2026, with the low at $5.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	3.01 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	750.00 Mn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	1.34 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	243.40 Mn
10	TransMedics	3.28 Bn	2.80 Bn	113.20 Mn	20.00 Mn

Download Data